Lacryvisc

Carbomer 974P, the active ingredient in Lacryvisc, is a viscosity agent presented as an ophthalmic solution for ocular use. It increases the lubricating film on the eye surface to relieve dryness and irritation in patients with ocular surface disorders.

GNH USA supplies Lacryvisc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lacryvisc is an ocular viscosity agent used to manage conditions affecting the tear film and ocular surface. - Dry eye disease: provides long‑lasting lubrication to relieve dryness and irritation. - Contact lens discomfort: reduces friction and improves comfort during lens wear. - Post‑operative ocular irritation: protects the cornea and promotes healing after eye surgery. - Environmental eye strain: mitigates dryness caused by low humidity or wind exposure.

Lacryvisc may cause ocular reactions, most of which are mild and transient.

Common Side Effects: - Transient blurred vision: temporary visual disturbance after instillation. - Mild ocular irritation: sensation of burning or stinging. - Tearing: increased tear production. - Redness of the conjunctiva: mild hyperemia.

Serious or Rare Side Effects: - Allergic reaction: swelling, itching, or rash around the eye. - Severe eye inflammation: marked redness, pain, or swelling. - Corneal ulceration or vision loss: rare but requires immediate medical attention.

Before using Lacryvisc, consider the following safety measures. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Pre‑existing eye infection: consult a clinician before application. - Contact lens wearers: remove lenses before instillation and re‑insert after a few minutes. - Use with caution in patients undergoing ocular surgery. - Store at room temperature: keep in the original container, protect from light and moisture.

Lacryvisc may interact with other ophthalmic products; monitor for combined effects.

Major Interactions (Avoid): - Concurrent use with ophthalmic solutions containing preservatives that can increase irritation. - Simultaneous administration with topical antibiotics that may be diluted, reducing efficacy.

Moderate Interactions (Monitor Closely): - Use with other ocular lubricants may cause excess viscosity and blurred vision. - Combination with anti‑inflammatory eye drops may alter drug distribution on the surface.